Uses and methods of bispecific antibody-drug conjugates for treating tumor diseases

TW202635350APending Publication Date: 2026-09-01SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114140403
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-10
Filing Date
2025-10-20
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074412_001
    Figure TWG2TA001074412_001
  • Figure TWG2TA001074412_002
    Figure TWG2TA001074412_002
  • Figure TWG2TA001074412_003
    Figure TWG2TA001074412_003
Patent Text Reader

Abstract

The present application relates to the use of antibody-drug conjugates in treating diseases associated with abnormal cell activity in subjects, such as tumors, wherein the relevant genes of the subjects suffering from the tumors are mutant or wild-type, and they have undergone or have not undergone first-line or second-line treatment.
Need to check novelty before this filing date? Find Prior Art